Cargando…

Proton pump inhibitors and histamine-2-receptor antagonists and pancreatic cancer risk: a nested case–control study

BACKGROUND: The relationship between use of proton pump inhibitors (PPIs) and histamine-2-receptor antagonists (H(2)RAs) and pancreatic cancer risk has yet to be examined. Data from a range of studies suggest biologically plausible mechanisms, whereby these drugs (or the conditions for which they ar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bradley, M C, Murray, L J, Cantwell, M M, Hughes, C M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2012
Materias:	Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3251858/ https://www.ncbi.nlm.nih.gov/pubmed/22108522 http://dx.doi.org/10.1038/bjc.2011.511

Ejemplares similares

Non-steroidal anti-inflammatory drugs and pancreatic cancer risk: a nested case–control study
por: Bradley, M C, et al.
Publicado: (2010)

Proton pump inhibitors and risk of periampullary cancers—A nested case–control study
por: Chien, Li‐Nien, et al.
Publicado: (2015)

Association of proton pump inhibitors and concomitant drugs with risk of acute kidney injury: a nested case–control study
por: Ikuta, Keiko, et al.
Publicado: (2021)

Association of proton pump inhibitor and histamine H(2)-receptor antagonists with restless legs syndrome
por: Earley, Eric J, et al.
Publicado: (2020)

Proton pump inhibitors and chronic kidney disease risk: a comparative study with histamine-2 receptor antagonists
por: Kweon, Takhyeon, et al.
Publicado: (2023)

Use of proton pump inhibitors and histamine-2 receptor antagonists and risk of gastric cancer in two population-based studies
por: Liu, Peipei, et al.
Publicado: (2020)

Do Histamine-2 Receptor Antagonists and Proton Pump Inhibitors Really Have No Effect on the Gastric Emptying Rate?
por: Tomita, Toshihiko, et al.
Publicado: (2011)

Comparison and Analysis of Delirium Induced by Histamine H(2) Receptor Antagonists and Proton Pump Inhibitors in Cancer Patients
por: Fujii, Shiro, et al.
Publicado: (2012)

Comparison of proton pump inhibitors and histamine 2 receptor antagonists for stress ulcer prophylaxis in the intensive care unit
por: Song, Myung Jin, et al.
Publicado: (2021)

Proton pump inhibitors and risk of gastric cancer: a population-based cohort study
por: Poulsen, A H, et al.
Publicado: (2009)

Do Histamine-2 Receptor Antagonists and Proton Pump Inhibitors Really Have No Effect on the Gastric Emptying Rate?: Author's Reply
por: Nonaka, Takashi, et al.
Publicado: (2011)

Effects of proton pump inhibitors and histamine-2 receptor antagonists on response to fidaxomicin or vancomycin in patients with Clostridium difficile-associated diarrhoea
por: Weiss, Karl, et al.
Publicado: (2015)

Influence of Proton Pump Inhibitors and Histamine Receptor 2 Antagonists on Blastocystis ST3 and Selected Microorganisms of Intestinal Microbiota In Vitro
por: Lepczyńska, Małgorzata, et al.
Publicado: (2021)

The Association of Long-Term Use of Proton Pump Inhibitors and Histamine H(2) Receptor Antagonists with Clinical Complications in Patients with Severe Sepsis
por: Gao, Jiamin, et al.
Publicado: (2022)

Inflammation marker and risk of pancreatic cancer: a nested case–control study within the EPIC cohort
por: Grote, V A, et al.
Publicado: (2012)

Prolonged Use of Proton Pump Inhibitors, but Not Histamine-2 Receptor Antagonists, Is Associated With Lower Bone Mineral Density in Males Aged Over 70
por: Gao, Shihua, et al.
Publicado: (2021)

Candida colonization of the esophagus and gastric mucosa; a comparison of patients taking proton pump inhibitors and those taking histamine receptor antagonist drugs
por: Mottaghi, Batoul, et al.
Publicado: (2021)

Comparing the Safety and Efficacy of Proton Pump Inhibitors and Histamine-2 Receptor Antagonists in the Management of Patients With Peptic Ulcer Disease: A Systematic Review
por: Begg, Maha, et al.
Publicado: (2023)

Proton Pump Inhibitor Use is Associated With Risk of Pancreatic Cancer: A Nested Case–Control Study
por: Peng, Yen-Chun, et al.
Publicado: (2018)

Exposure to cyclooxygenase-2 inhibitors and risk of cancer: nested case–control studies
por: Vinogradova, Y, et al.
Publicado: (2011)

Proton Pump Inhibitors: Current Use and the Risk of Coronavirus Infectious Disease 2019 Development and its Related Mortality. Meta-analysis
por: Toubasi, Ahmad Amjed, et al.
Publicado: (2021)

Metformin With Either Histamine H2-Receptor Antagonists or Proton Pump Inhibitors: A Polypharmacy Recipe for Neuropathy via Vitamin B(12) Depletion
por: Zdilla, Matthew J.
Publicado: (2015)

Impact of Proton Pump Inhibitors and Histamine-2-Receptor Antagonists on Non-Small Cell Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis
por: Rizzo, Alessandro, et al.
Publicado: (2022)

Dietary glycaemic index, glycaemic load and breast cancer risk: a systematic review and meta-analysis
por: Mulholland, H G, et al.
Publicado: (2008)

Proton pump inhibitors versus histamine-2 receptor antagonists for stress ulcer prophylaxis during extracorporeal membrane oxygenation: a propensity score-matched analysis
por: Kondo, Yutaka, et al.
Publicado: (2020)

Effects of Proton Pump Inhibitors and H(2) Receptor Antagonists on the Ileum Motility
por: Kurt, Atilla, et al.
Publicado: (2011)

Comparative risk of incidence and clinical outcomes of COVID-19 among proton pump inhibitor and histamine-2 receptor antagonist short-term users: a nationwide retrospective cohort study
por: Park, Jimyung, et al.
Publicado: (2022)

Histamine2-Receptor Antagonists, Proton Pump Inhibitors, or Potassium-Competitive Acid Blockers Preventing Delayed Bleeding After Endoscopic Submucosal Dissection: A Meta-Analysis
por: Jiang, Xin, et al.
Publicado: (2019)

Stress ulcer prophylaxis with proton pump inhibitors or histamine 2 receptor antagonists in critically ill adults - a meta-analysis of randomized controlled trials with trial sequential analysis
por: Zhou, Xiaoyang, et al.
Publicado: (2019)

H(2) antagonists, proton pump inhibitors and COVID-19
por: Hirota, Kazuyoshi
Publicado: (2022)

Use of non-steroidal anti-inflammatory drugs and proton pump inhibitors in correlation with incidence, recurrence and death of peptic ulcer bleeding: an ecological study
por: Lu, Yunxia, et al.
Publicado: (2013)

Comparison of the Hospital-Acquired Clostridium difficile Infection Risk of Using Proton Pump Inhibitors versus Histamine-2 Receptor Antagonists for Prophylaxis and Treatment of Stress Ulcers: A Systematic Review and Meta-Analysis
por: Azab, Mohamed, et al.
Publicado: (2017)

Comparison of Proton Pump Inhibitor and Histamine-2 Receptor Antagonist in the Prevention of Recurrent Peptic Ulcers/Erosions in Long-Term Low-Dose Aspirin Users: A Retrospective Cohort Study
por: Chen, Wen-Chi, et al.
Publicado: (2014)

Influence of proton pump inhibitors and histamine H(2) receptor antagonists on serum phosphorus level control by calcium carbonate in patients undergoing hemodialysis: a retrospective medical chart review
por: Tatsuzawa, Masaomi, et al.
Publicado: (2016)

Interactions between epidermal growth factor receptor tyrosine kinase inhibitors and proton-pump inhibitors/histamine type-2 receptor antagonists in non-small cell lung cancer: a systematic review and meta-analysis
por: Sim, Wilson, et al.
Publicado: (2021)

Comparing proton pump inhibitors with histamin-2 receptor blockers regarding the risk of osteoporotic fractures: a nested case-control study of more than 350,000 Korean patients with GERD and peptic ulcer disease
por: Park, Joo-Hyun, et al.
Publicado: (2020)

Lignans and breast cancer risk in pre- and post-menopausal women: meta-analyses of observational studies
por: Velentzis, L S, et al.
Publicado: (2009)

Histamine-2 receptor antagonists versus proton pump inhibitors for septic shock after lower gastrointestinal tract perforation: a retrospective cohort study using a national inpatient database
por: Suzuki, Jun, et al.
Publicado: (2020)

Proton pump inhibitors versus histamine-2 receptor blockers for stress ulcer prophylaxis in patients with sepsis: a retrospective cohort study
por: Huang, Minqiang, et al.
Publicado: (2021)

Neighbourhood deprivation and lung cancer risk: a nested case–control study in the USA
por: Sanderson, Maureen, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_cvdv14c9qtehq6sop655jr6hvo